The PROACTIVE Study for Black Elders
Launched by UNIVERSITY OF FLORIDA · Jul 16, 2024
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
The PROACTIVE Study for Black Elders is researching a new way to help older Black individuals manage chronic musculoskeletal pain (CMP), which is pain that affects bones, joints, and muscles and lasts for six months or longer. This study aims to create a culturally appropriate program that supports self-management of pain, focusing specifically on how movement can impact pain levels. They are looking for 120 participants aged 50 to 92 who identify as Black or African American and experience ongoing pain in areas like the hips, knees, or lower back.
To join the study, participants should self-identify as part of the Black American community, report chronic pain symptoms, and have access to healthcare insurance in Florida. Over the course of three years, participants will be involved in activities and assessments to track their pain levels during movement. This study is not yet recruiting but aims to address a significant health issue affecting Black communities and improve the quality of life for those living with chronic pain.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Self-identify as being part of the Black American diaspora (Black/African American, Afro-Caribbean)
- • 2. Age 50-92 years
- • 3. Self-report chronic musculoskeletal pain (CMP) as defined as persistent or recurrent pain lasting 6 months or longer that arises as part of a disease or injurious process directly affecting bone(s), joint(s), muscle(s), or related soft tissue(s)
- • 4. Self-report a chronic musculoskeletal condition (e.g., osteoarthritis, chronic low back pain) in at least one lower extremity joint (hip, knee, low back, or ankle pain)
- • 5. Report chronic musculoskeletal symptoms: aching, stiffness, or swelling in a major lower extremity joint or low back on most days (4-5/7) of the week
- • 6. Have (or be eligible for) a healthcare insurance plan in the state of Florida (Medicare, Medicaid, Medicare Advantage plans, Blue Cross/Blue Shield, Humana, Aetna, etc.)
- • 7. Able to read, write, and understand English at sixth-grade level
- Exclusion Criteria:
- • 1. Unwilling to be randomized to either study arm
- • 2. Self-reported diagnosis of sickle cell disease or related thalassemias
- • 3. History of major neurological event (e.g., stroke) or current neurological disease (e.g., Parkinson's disease, multiple sclerosis, epilepsy)
- • 4. Major cardiovascular problem in the past 6 months that would cause shortness of breath and/or chest pain (e.g. myocardial infarction, coronary artery bypass graft, or valve replacement, pulmonary embolism or deep venous thrombosis) or uncontrolled Hypertension (Systolic Blood Pressure (SBP) \> 170 mmHg, Diastolic Blood Pressure (DBP) \> 90 mmHg) OR Hypotension (SBP \<90 mmHg, DBP \<60 mmHg)
- • 5. Currently undergoing curative or palliative chemotherapy or radiation for active cancer
- • 6. Severe physical impairment (e.g., a major activity of daily living disability requiring use of wheelchair as primary method of mobility, or unable to dress, bath, use the toilet, or transfer independently)
- • 7. Serious mental health disorder requiring hospitalization within past 12 months
- • 8. Severe sensory deficit (severe hearing loss or blindness)
About University Of Florida
The University of Florida, a leading research institution, is dedicated to advancing healthcare through innovative clinical trials. With a focus on enhancing patient outcomes and exploring new therapeutic avenues, the university leverages its extensive resources, interdisciplinary expertise, and state-of-the-art facilities to conduct rigorous research across a variety of medical fields. Committed to ethical standards and patient safety, the University of Florida fosters collaboration among researchers, healthcare professionals, and community stakeholders to translate scientific discoveries into impactful clinical applications.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Gainesville, Florida, United States
Patients applied
Trial Officials
Staja Q Booker, PhD, RN
Principal Investigator
University of Florida
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported